As early as July 1st, Stefan Olsson the position of communications manager in Enzymatica (SwedenBIO/EuropaBio), while Charlotte Andersson will take up his position as Director Quality Assurance on September 1. According to a press release, Enzymatica's COO is Claus Egstrand convinced that the two new members of the management team will make valuable contributions to the company's international expansion:
»We are very pleased to have recruited two such experienced and competent employees. They will have a lot to contribute to Enzymatica's continued international expansion« — Claus Egstrand, Chief Operating Officer

Charlotte Andersson – expert in QA
Charlotte Andersson replaces Asa Anderlind in the role of Director Quality Assurance as Anderlind has chosen to end her time at Enzymatica in favor of other assignments.
Andersson has significant experience in quality work for medical devices, in vitro diagnostics (IVD) and in the pharmaceutical and biotechnology fields. She most recently came from a position as Senior Quality Assurance Advisor in Bioinvent, but she has previously also worked with quality assurance (QA) in Wieslab, EuroDiagnostica, Orifice Medical and NovoZymes Biopharma SwedenThrough her various positions, she has gained broad expertise in, among other things, ISO standards, Good Manufacturing Practice (GMP), Good Clinical Practice (GCP) and Good Laboratory Practice (GLP).

Stefan Olsson has a long experience in communication
Stefan Olsson will be co-opted to the management team, succeeding the current head of communications. Carl Johan Wachtmeister who is retiring. Olsson has extensive experience in the communications industry and has previously worked at agencies such as Prime Weber Shandwick and Healthy Communication and as a management consultant at KPMG.
For the past six years, he has been working as an independent communications advisor to management teams and boards of directors in both listed and unlisted companies as well as public organizations.
Expansive phase
This is not Enzymatica's first recruitments to the management team in 2021. During the opening months of the year, Malin Richter the role of Director Operations and Kristoffer Ahlerup as Director Commercial. Read BioStock's article about this here.
The recruitment of Malin Richter and Kristoffer Ahlerup was made as part of supporting the company's growth, says Claus Egstrand in a press release:
»We have so much more growth ahead of us that will require us to continuously strengthen our capabilities and resources in our organization«
The content of BioStock's news and analysis is independent, but BioStock's operations are to some extent financed by companies in the industry. This post refers to a company from which BioStock has received funding.